1
|
Lee E, Park HS, Han S, Nam GB, Choi JI, Pak HN, Oh IY, Shin DG, On YK, Park SW, Kim YH, Oh S, Ahn J, Ahn MS, Baek YS, Cha MJ, Cha TJ, Choi EK, Choi HO, Choi JI, Chun KJ, Gwag HB, Han S, Hwang Y, Hyun DW, Jin ES, Kang KW, Kim DH, Kim DK, Kim D, Kim JH, Kim JB, Kim M, Kim SH, Kim YR, Kim YH, Ko JS, Kwak JJ, Lee E, Lee S, Lee SR, Lee SH, Lee YS, Nam GB, Namgung J, Oh IY, Oh S, Oh YS, On YK, Pak HN, Park HC, Park HS, Park HW, Park SW, Park YM, Park YA, Rhee KS, Shim J, Shin DG, Song IG, Sung JH, Yang PS. Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA). INTERNATIONAL JOURNAL OF ARRHYTHMIA 2021. [DOI: 10.1186/s42444-021-00047-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
This study aims to investigate the current status of AF (atrial fibrillation) catheter ablation in Korea.
Methods
The patients who underwent AF catheter ablation from September 2017 to December 2019 were prospectively enrolled from 37 arrhythmia centers. Demographic data, procedural characteristics, the extent of catheter ablation, acute success of the ablation lesion set, rate and independent risk factor for recurrence of AF were analyzed.
Results
A total of 2402 AF patients [paroxysmal AF (PAF) 45.7%, persistent AF (PeAF) 43.1% and redo AF 11.2%] were included. Pulmonary vein isolation (PVI) was performed in 2378 patients (99%) and acute success rate was 97.9%. Additional non-PV ablation (NPVA) were performed in 1648 patients (68.6%). Post-procedural complication rate was 2.2%. One-year AF-free survival rate was 78.6% and the PeAF patients showed poorer survival rate than the ones with other types (PeAF 72.4%, PAF 84.2%, redo AF 80.0%). Additional NPVA did not influence the recurrence of AF in the PAF patients (PVI 17.0% vs. NPVA 14.6%, P value 0.302). However, it showed lower AF recurrence rate in the PeAF patients (PVI 34.9% vs. NPVA 24.4%, P value 0.001). Valvular heart disease, left atrial diameter, PeAF, PVI alone, need of NPVA for terminating AF, and failed ablation were independent predictors of AF recurrence.
Conclusions
Additional NPVA was associated better rhythm outcome in the patients with PeAF, not in the ones with PAF. The independent risk factors for AF recurrence in Korean population were similar to previous studies. Further research is needed to discover optimal AF ablation strategy.
Collapse
|
2
|
Siontis KC, Noseworthy PA. Down but not out-addressing the scourge of late pulmonary vein reconnection. J Cardiovasc Electrophysiol 2019; 30:824-826. [PMID: 30887591 DOI: 10.1111/jce.13903] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 02/28/2019] [Indexed: 12/01/2022]
Affiliation(s)
- Konstantinos C Siontis
- Department of Cardiovascular Medicine, Mayo Clinic, College of Medicine, Rochester, Minnesota
| | - Peter A Noseworthy
- Department of Cardiovascular Medicine, Mayo Clinic, College of Medicine, Rochester, Minnesota.,Division of Health Care Policy and Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
3
|
Skala T, Precek J, Hutyra M, Moravec O, Tudos Z, Skalova J, Klementova O, Antonicka A, Zapletalova J, Taborsky M. Long-term outcome of paroxysmal atrial fibrillation catheter ablation with and without pulmonary vein dormant conduction after adenosine challenge. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019; 164:147-153. [PMID: 30829343 DOI: 10.5507/bp.2019.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Accepted: 02/26/2019] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVES The prognostic significance of adenosine-mediated pulmonary vein (PV) dormant conduction is unclear. We prospectively followed patients with adenosine-mediated PV reconduction with a subsequent repeated ablation until there was no reconduction inducible with patients without reconduction after PV isolation. METHOD AND RESULTS Consecutive patients (n=179) with paroxysmal atrial fibrillation (AF) without prior catheter ablation (CA) were enlisted in the study. We used a point-by-point CA and general anesthesia in all patients. Twenty minutes after PV isolation we administered adenosine in a dose sufficient to produce an atrioventricular block. If a dormant conduction was present (n=54) we performed additional ablation until there was no adenosine mediated reconduction inducible. During 36 months of follow-up, all patients were examined for eight 7-day ECG recordings. There was no difference in arrhythmia recurrence rate between patients with and without dormant conduction (29.6 vs. 24.8% at 12 months, P=0.500; 31.5 vs. 30.4% at 36 months, P=1.000), for any echocardiographic parameter or any parameter of the ablation procedure. CONCLUSION The patients with dormant conduction after adenosine during catheter ablation of paroxysmal atrial fibrillation with complete elimination of the dormant conduction by additional extensive ablation have the same outcome in the long term as patients without a dormant conduction.
Collapse
Affiliation(s)
- Tomas Skala
- Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
| | - Jan Precek
- Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
| | - Martin Hutyra
- Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
| | - Ondrej Moravec
- Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
| | - Zbynek Tudos
- Department of Radiology, University Hospital Olomouc, Czech Republic
| | - Jitka Skalova
- Department of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc, Czech Republic
| | - Olga Klementova
- Department of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc, Czech Republic
| | - Andrea Antonicka
- Cardiovascular Center, Tomas Bata County Hospital, Zlin, Czech Republic
| | - Jana Zapletalova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
| | - Milos Taborsky
- Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
| |
Collapse
|
4
|
No association between dormant conduction sites and pulmonary vein reconnection sites in late atrial fibrillation recurrence after catheter ablation. J Cardiol 2018; 72:488-493. [PMID: 30318077 DOI: 10.1016/j.jjcc.2018.05.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Revised: 04/20/2018] [Accepted: 05/07/2018] [Indexed: 11/23/2022]
Abstract
OBJECTIVE Despite use of provocation testing to unmask dormant left atrium (LA)-PV conduction after index pulmonary vein isolation (PVI) for atrial fibrillation (AF), AF recurrence still occurs, with PV reconnection as the main cause. In an effort to answer the question whether freedom from AF recurrence can be achieved by ablation that targets sites of dormant conduction, we compared sites of dormant conduction against sites of PV reconnection identified at the time of repeat ablation for AF recurrence. MATERIALS AND METHODS The study group comprised 46 patients (30 men/16 women, aged 58.7±10.3 years) with AF (paroxysmal: n=37, persistent: n=9) who underwent repeat ablation for AF recurrence 12.3 (7.4-29.7) months after the index ablation procedure. Ipsilateral PVs were divided into 8 segments each (736 total segments), and the relation between dormant conduction sites and PV reconnection sites was determined per segment. RESULTS Dormant LA-PV conduction was unmasked and ablated in 22 (47.8%) of the 46 patients at sites within 43 (5.8%) of the 736 PV segments. Late PV reconnection was found within 122 (17%) of the 736 PV segments at the time of re-ablation for AF recurrence. Only 22 (18%) of these 122 PV segments corresponded to dormant conduction sites identified during the index procedure. CONCLUSION Although additional ablation to eliminate dormant PV conduction unmasked during the index ablation procedure is performed, the majority of PVs that show reconduction at the time of treatment for clinical AF recurrence are PVs that have not shown dormant conduction.
Collapse
|
5
|
Afzal MR, Kahaly O, Weiss R, Houmsse M, Daoud EG, Hummel JD. Adenosine triphosphate/adenosine guided pulmonary vein isolation does not improve the outcomes of ablation: a meta-analysis of randomized controlled trials. Expert Rev Cardiovasc Ther 2018; 16:313-318. [PMID: 29561176 DOI: 10.1080/14779072.2018.1455500] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND Successful pulmonary vein isolation (PVI) is the most reliable predictor of success after ablation in patients with atrial fibrillation (AF). Adenosine triphosphate (ATP) unmasks the dormant conduction and can be used to improve the effectiveness of PVI. The impact of ATP guided PVI on clinical outcomes is discordant in various randomized controlled trials (RCTs). OBJECTIVES To delineate the incremental benefit of ATP during PVI in patients with AF through a meta-analysis. METHODS AND RESULTS Database searches through January 2017 identified 5 RCTs (enrolling 2839 patients) comparing ATP guided PVI versus standard PVI (non-ATP). Four trials exclusively studied paroxysmal AF while one trial included both paroxysmal and non-paroxysmal AF patients. Baseline characteristics, dose of adenosine and ablation strategies were clearly identified among all the trials. The risk ratio (RR) for AF episodes lasting >30 s after 3-month blanking period was calculated with random effects meta-analysis and showed no difference at a median follow up of 12 months [RR: 1.02, 95 % Confidence interval (CI): 0.85 to 1.25; p = 0.82]. Similarly, the number of repeat ablation was similar in both groups [RR: 1.02, 95 % CI: 0.63, 1.56; p = 0.98]. CONCLUSIONS ATP guided PVI does not decrease the recurrence of AF or the need for repeat ablation at 12 months.
Collapse
Affiliation(s)
- Muhammad R Afzal
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| | - Omar Kahaly
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| | - Raul Weiss
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| | - Mahmoud Houmsse
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| | - Emile G Daoud
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| | - John D Hummel
- a Division of Cardiovascular Medicine, Department of Internal Medicine, Electrophysiology Section , Ross Heart Hospital, The Wexner Medical Center at the Ohio State University Medical Center , Columbus , OH , USA
| |
Collapse
|
6
|
Yamaguchi T, Shimakawa Y, Mitsumizo S, Fukui A, Kawano Y, Otsubo T, Takahashi Y, Hirota K, Tsuchiya T, Eshima K. Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation. J Cardiol 2018; 72:19-25. [PMID: 29338895 DOI: 10.1016/j.jjcc.2017.12.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Revised: 12/08/2017] [Accepted: 12/13/2017] [Indexed: 12/22/2022]
Abstract
BACKGROUND The optimal methodology for sedation and anesthesia during atrial fibrillation (AF) ablation has not been well established. We assessed the feasibility of total intravenous anesthesia (TIVA) by cardiologists with support from anesthesiologists during AF ablation and quality of pulmonary vein isolation (PVI) and single procedure success rate at 12 months. METHODS TIVA was performed by cardiologists using IV propofol and fentanyl under controlled ventilation via i-gel™ without neuromuscular blocking drugs in 160 consecutive patients (80 nonparoxysmal) with no anticipated difficult airway or other severe diseases. Anesthesiologists were requested to be on standby during the procedure. The incidence of anesthesia-associated complications and ablation-associated complications were assessed. To evaluate the quality of PVI, the prevalence of acute adenosine triphosphate (ATP)-provoked PV reconnections and late PV reconnections among those requiring a redo procedure was analyzed. RESULTS TIVA was successfully completed in 152 patients (95%). In five (3%), we requested help from anesthesiologists, and in three (2%), TIVA was abandoned. No major anesthesia-associated complications were observed. Ablation-associated complications were observed in seven patients (4%). ATP provocation test was performed in 141 patients, and no acute PV reconnections were observed in 134 (95%). Success rates at 12 months were 85% of patients off antiarrhythmic drugs. Twenty-one of 24 patients with recurrence underwent a redo session, and 18 (86%) had no PV reconnections. CONCLUSIONS TIVA by cardiologists with support from anesthesiologists during AF ablation may be feasible. The success rate at 12 months was high, and prevalence of acute and late PV reconnection was very low.
Collapse
Affiliation(s)
- Takanori Yamaguchi
- Department of Cardiology, Saga-ken Medical Centre Koseikan, Saga, Japan.
| | - Yusuke Shimakawa
- Department of Anesthesiology, Saga-ken Medical Centre Koseikan, Saga, Japan
| | - Shinji Mitsumizo
- Department of Intensive Care Unit, Saga-ken Medical Centre Koseikan, Saga, Japan
| | - Akira Fukui
- EP Expert Doctors-Team Tsuchiya, Kumamoto, Japan
| | - Yuki Kawano
- Department of Cardiology, Saga-ken Medical Centre Koseikan, Saga, Japan
| | | | | | - Kei Hirota
- EP Expert Doctors-Team Tsuchiya, Kumamoto, Japan
| | | | - Kenichi Eshima
- Department of Cardiology, Saga-ken Medical Centre Koseikan, Saga, Japan
| |
Collapse
|
7
|
Wang N, Phan S, Kanagaratnam A, Kumar N, Phan K. Adenosine Testing After Atrial Fibrillation Ablation: Systematic Review and Meta-Analysis. Heart Lung Circ 2017; 27:601-610. [PMID: 28655535 DOI: 10.1016/j.hlc.2017.04.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Accepted: 04/20/2017] [Indexed: 10/19/2022]
Abstract
BACKGROUND Adenosine can be used to reveal dormant pulmonary vein (PV) conduction after pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF). We performed a systematic review and meta-analysis to assess the impact of adenosine administration in patients undergoing PVI for AF. METHODS Meta-analysis of 22 studies was performed to assess the rates of freedom from AF in 1) patients with dormant PV conduction versus patients without dormant PV conduction, and 2) patients given routine adenosine post PVI versus patients not given adenosine. Relative-risks (RR) were calculated using random effects modelling. RESULTS In 18 studies, 3038 patients received adenosine and freedom from AF in those patients with dormant PV reconnection was significantly lower (62.9%) compared to patients without PV reconnection (67.2%) (RR 0.87; 95% CI: 0.78-0.98). In seven studies with 3049 patients, the freedom from AF was significantly higher in patients who received adenosine (67%) versus those patients who did not receive adenosine (63%) (RR: 1.11; 95% CI: 1.01-1.22). CONCLUSIONS The present study showed clear benefits of adenosine testing for freedom from AF recurrence. Adenosine-guided dormant conduction is associated with higher AF recurrence despite further ablation. Future studies should investigate the optimal methodology, including dosage and waiting time between PVI and adenosine administration.
Collapse
Affiliation(s)
- Nelson Wang
- Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Collaborative Research (CORE) Group, Macquarie University, Sydney, NSW, Australia.
| | - Steven Phan
- Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Collaborative Research (CORE) Group, Macquarie University, Sydney, NSW, Australia
| | | | - Narendra Kumar
- Department of Cardiology, Paras HMRI Hospitals, Raja Bazar, Patna, India
| | - Kevin Phan
- Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Collaborative Research (CORE) Group, Macquarie University, Sydney, NSW, Australia
| |
Collapse
|
8
|
Vlachos K, Efremidis M, Bazoukis G, Letsas KP, Saplaouras A, Georgopoulos S, Karamichalakis N, Rokiza A, Sakellaropoulou A, Kolokathis AM, Efremidis T, Asvestas D, Sideris A. Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation. Clin Cardiol 2017; 40:847-852. [PMID: 28561951 DOI: 10.1002/clc.22734] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Revised: 04/26/2017] [Accepted: 05/01/2017] [Indexed: 01/31/2023] Open
Abstract
BACKGROUND Thromboembolic complications can be life-threatening during atrial fibrillation (AF) catheter ablation. The aim of our study was to evaluate the safety and efficacy of continuous treatment using direct oral anticoagulants (DOACs) as an alternative to uninterrupted acenocoumarol for periprocedural anticoagulation. HYPOTHESIS Continuous treatment with DOACs has similar safety and efficacy compared to acenocoumarol. METHODS We enrolled 474 patients (mean age, 58 years; 68.4% male) undergoing AF catheter ablation between June 2013 and December 2016. All patients were equally assigned to take acenocoumarol (group 1, 136 patients) or DOACs (group 2, 338 patients) for ≥2 months before the procedure. We compared thromboembolic and bleeding complications between the 2 groups. RESULTS Our analysis showed no significant difference in major and minor complications between the 2 patient groups. Specifically, 3 of 136 patients (2.2%) using uninterrupted acenocoumarol had a major complication (1 patient [0.7%] had transient ischemic attack resolved 8 hours later, 1 [0.7%] had pericardial tamponade, and 1 [0.7%] had a subcapsular renal hematoma) and 2 patients (1.4%) had minor complications (1 [0.7%] pseudoaneurysm and 1 [0.7%] groin hematoma). In group 2, 1 of 338 patients (0.3%) had a major complication (transient ischemic attack). In the same group, 7 patients (2.1%) had a minor complication (1 patient [0.3%] presented with pseudoaneurysm, 4 [1.2%] with pericardial effusion <1 cm, 1 [0.3%] femoral arteriovenous fistula between the femoral artery and femoral vein, and 1 [0.7%] groin hematoma). CONCLUSIONS DOACs and acenocoumarol have similar safety and effectiveness regarding thromboembolic complications prevention without increasing bleeding complications.
Collapse
Affiliation(s)
- Konstantinos Vlachos
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Michael Efremidis
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - George Bazoukis
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Konstantinos P Letsas
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Athanasios Saplaouras
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Stamatis Georgopoulos
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | | | - Aikaterini Rokiza
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | | | | | - Theodoros Efremidis
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Dimitrios Asvestas
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Antonios Sideris
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| |
Collapse
|
9
|
Letsas KP, Georgopoulos S, Efremidis M, Liu T, Bazoukis G, Vlachos K, Karamichalakis N, Lioni L, Sideris A, Ehrlich JR. Adenosine-guided radiofrequency catheter ablation of atrial fibrillation: A meta-analysis of randomized control trials. J Arrhythm 2017; 33:247-255. [PMID: 28765753 PMCID: PMC5529608 DOI: 10.1016/j.joa.2017.02.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 01/16/2017] [Accepted: 02/19/2017] [Indexed: 10/27/2022] Open
Abstract
BACKGROUND The prognostic significance of adenosine-mediated dormant pulmonary vein conduction, and whether such dormant conduction should be eliminated, remains controversial. We sought to perform a meta-analysis of data from eligible studies to delineate the prognostic impact of adenosine-guided radiofrequency catheter ablation of atrial fibrillation. METHODS A systematic literature search was performed using online databases in order to identify relevant studies from January 2004 to September 2016. Ten studies [six observational and four randomized control trials (RCTs)] were included in the analysis. RESULTS Five studies (two observational and three RCTs) compared the efficacy of adenosine-mediated elimination of dormant conduction versus no adenosine test. Overall, the adenosine-guided ablation strategy displayed better long-term outcomes as compared with no adenosine testing (RR 1.08, 95% CI 1.01-1.14, p=0.02; Heterogeneity: I2=42%, p: 0.14). The meta-analysis of only RCTs failed to show any differences between the two strategies (RR 1.03, 95% CI 0.96-1.11, p=0.37; Heterogeneity: I2 0%, p: 0.41). Eight studies (five observational and three RCTs) addressed the efficacy of adenosine-induced dormant conduction and additional ablation versus no dormant conduction during adenosine challenge. Overall, a trend towards a better outcome in those without dormant conduction during drug challenge was noted (RR 0.89, 95% CI 0.77-1.03, p=0.11; Heterogeneity: I2 65% p: 0.006). The pooled analysis of RCTs failed to show any differences between the two arms (RR 0.90, 95% CI 0.62-1.30, p= 0.57; Heterogeneity: I2 88%, p: 0.0002). CONCLUSIONS Adenosine-guided radiofrequency catheter ablation of atrial fibrillation does not provide additional benefit in terms of freedom of arrhythmia recurrence.
Collapse
Affiliation(s)
- Konstantinos P Letsas
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Stamatis Georgopoulos
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Michael Efremidis
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Tong Liu
- Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, People׳s Republic of China
| | - George Bazoukis
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Konstantinos Vlachos
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | | | - Louiza Lioni
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | - Antonios Sideris
- Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Greece
| | | |
Collapse
|
10
|
PRABHU SANDEEP, MACKIN VINCENT, MCLELLAN ALEXJ, PHAN TUONG, MCGLADE DESMOND, LING LIANGHAN, PECK KAHY, VOSKOBOINIK ALEXANDR, PATHIK BUPESH, NALLIAH CHRISHANJ, WONG GEOFFR, AZZOPARDI SONIAM, LEE GEOFFREY, MARIANI JUSTIN, TAYLOR ANDREWJ, KALMAN JONATHANM, KISTLER PETERM. Determining the Optimal Dose of Adenosine for Unmasking Dormant Pulmonary Vein Conduction Following Atrial Fibrillation Ablation: Electrophysiological and Hemodynamic Assessment. DORMANT-AF Study. J Cardiovasc Electrophysiol 2016; 28:13-22. [DOI: 10.1111/jce.13107] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Revised: 09/05/2016] [Accepted: 09/07/2016] [Indexed: 11/28/2022]
Affiliation(s)
- SANDEEP PRABHU
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | | | - ALEX J.A. MCLELLAN
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | - TUONG PHAN
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | | | - LIANG-HAN LING
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | - KAH Y. PECK
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
| | - ALEXANDR VOSKOBOINIK
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | - BUPESH PATHIK
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
| | - CHRISHAN J. NALLIAH
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
| | - GEOFF R. WONG
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
| | - SONIA M. AZZOPARDI
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
| | - GEOFFREY LEE
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
| | - JUSTIN MARIANI
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
| | - ANDREW J. TAYLOR
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| | - JONATHAN M. KALMAN
- Cardiology Department; Royal Melbourne Hospital; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
| | - PETER M. KISTLER
- Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia
- Baker IDI Heart and Diabetes Institute; Cabrini Health; Melbourne Victoria Australia
- Faculty of Medicine, Dentistry, and Health Sciences; University of Melbourne; Melbourne Victoria Australia
- Cabrini Health; Melbourne Victoria Australia
| |
Collapse
|
11
|
Goldberger JJ, Mitrani RD. Cryoballoon Ablation for Atrial Fibrillation: Double Jeopardy? J Cardiovasc Electrophysiol 2016; 27:1381-1383. [PMID: 27682855 DOI: 10.1111/jce.13103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Jeffrey J Goldberger
- Division of Cardiology, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Raul D Mitrani
- Division of Cardiology, University of Miami Miller School of Medicine, Miami, Florida, USA
| |
Collapse
|